<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" href="https://www.taxtmi.com/rss_sitemap/rss_feed_blog.xsl?v=1750492856"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Fee on Generic Drugs Sale Application</title>
    <link>https://www.taxtmi.com/news?id=4975</link>
    <description>The Generic Drugs User Fee Act 2012 imposes prescribed user fees on registration submissions for generic pharmaceuticals to fund and expedite application review and inspections, applying to both domestic and international manufacturers and tying fees to specific filing categories such as abbreviated new drug applications and drug master files.</description>
    <language>en-us</language>
    <pubDate>Mon, 11 Mar 2013 16:31:27 +0530</pubDate>
    <lastBuildDate>Mon, 11 Mar 2013 16:31:27 +0530</lastBuildDate>
    <generator>TaxTMI RSS Generator</generator>
    <atom:link href="https://www.taxtmi.com/rss_feed_blog?id=307703" rel="self" type="application/rss+xml"/>
    <item>
      <title>Fee on Generic Drugs Sale Application</title>
      <link>https://www.taxtmi.com/news?id=4975</link>
      <description>The Generic Drugs User Fee Act 2012 imposes prescribed user fees on registration submissions for generic pharmaceuticals to fund and expedite application review and inspections, applying to both domestic and international manufacturers and tying fees to specific filing categories such as abbreviated new drug applications and drug master files.</description>
      <category>News</category>
      <law>-</law>
      <pubDate>Mon, 11 Mar 2013 16:31:27 +0530</pubDate>
      <guid isPermaLink="true">https://www.taxtmi.com/news?id=4975</guid>
    </item>
  </channel>
</rss>